
AYRSF
Healthcare · Drug Manufacturers - Specialty & Generic · $458.1M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 18, 2020 | Time not confirmed | -0.13 | -0.96 | -638.5% |
| Aug 26, 2020 | Time not confirmed | -0.14 | -0.28 | -100.0% |
| May 20, 2020 | Time not confirmed | -0.22 | 0.05 | +122.7% |
| Feb 26, 2020 | Time not confirmed | -0.25 | -0.65 | -160.0% |
| Nov 18, 2019 | Time not confirmed | -0.06 | 0.84 | +1500.0% |
| Aug 14, 2019 | Time not confirmed | 0.07 | -2.34 | -3442.9% |
Ayr Strategies Inc., a vertically-integrated cannabis multi-state operator, cultivates and manufactures branded cannabis products for distribution through its network of retail outlets and through third-party stores primarily in Massachusetts and Nevada. The company was incorporated in 2017 and is headquartered in New York, New York.